The road to crisis: State of Pakistan’s Research Output in Dementia

Tehniat Faraz Ahmed, Affan Ahmed
{"title":"The road to crisis: State of Pakistan’s Research Output in Dementia","authors":"Tehniat Faraz Ahmed, Affan Ahmed","doi":"10.47391/jpma.9548","DOIUrl":null,"url":null,"abstract":"Dear Madam, With an estimated 6.5 million people living with dementia in the South Asian region, these areas are at the forefront of tackling the growing epidemic. However, there is a scarcity of population-based studies particularly in lower-middle-income countries, which hampers accurate estimation of the economic burden posed by dementia (1). Pakistan, with the world’s third largest growing population is a model of these countries. Although the Global Action Plan for Public Health Response to Dementia highlights seven action areas, the Global Dementia Observatory (GDO) report has Pakistan underperforming in almost all areas. In comparison, her neighbors, India, China and Iran are significantly better. With no health information systems for dementia, and no support or care for people with dementia, Pakistan has failed to consider dementia as a public health priority (1). Reports show that Pakistan is drafting a national policy for dementia, yet no surveys on national prevalence and cost have been conducted (2). Apart from an ageing population, low literacy levels and high prevalence of heart diseases and diabetes, make the population highly susceptible to developing AD in the coming future. Furthermore, a challenge especially to LMICs is the stigma associated with dementia and the lack of awareness, not just in the general population, but also in the healthcare providers. Alzheimer’s Disease International reports that almost 2 in 3 healthcare practitioners worldwide consider dementia as part of normal ageing (3). Only if these beliefs are reformed can the disease be tackled efficiently. For a nation with no infrastructure to support patients with AD and where MRI is unaffordable to the majority and scarcely available PET scans are not used for the diagnosis of AD, the population would rely on the establishment of fluid biomarkers not only for diagnosing AD, but for its identification at a stage where it is possible to reduce the years lost to dependence. Unfortunately, our search on PubMed and Google Scholar revealed only one AD biomarker study conducted by the current authors on our population (4). Recently a constructive step was taken by lay and professional experts where a SWOT analysis was done of dementia research capacity in Pakistan. ---Continue","PeriodicalId":16673,"journal":{"name":"Journal of Pakistan Medical Association","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pakistan Medical Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47391/jpma.9548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Madam, With an estimated 6.5 million people living with dementia in the South Asian region, these areas are at the forefront of tackling the growing epidemic. However, there is a scarcity of population-based studies particularly in lower-middle-income countries, which hampers accurate estimation of the economic burden posed by dementia (1). Pakistan, with the world’s third largest growing population is a model of these countries. Although the Global Action Plan for Public Health Response to Dementia highlights seven action areas, the Global Dementia Observatory (GDO) report has Pakistan underperforming in almost all areas. In comparison, her neighbors, India, China and Iran are significantly better. With no health information systems for dementia, and no support or care for people with dementia, Pakistan has failed to consider dementia as a public health priority (1). Reports show that Pakistan is drafting a national policy for dementia, yet no surveys on national prevalence and cost have been conducted (2). Apart from an ageing population, low literacy levels and high prevalence of heart diseases and diabetes, make the population highly susceptible to developing AD in the coming future. Furthermore, a challenge especially to LMICs is the stigma associated with dementia and the lack of awareness, not just in the general population, but also in the healthcare providers. Alzheimer’s Disease International reports that almost 2 in 3 healthcare practitioners worldwide consider dementia as part of normal ageing (3). Only if these beliefs are reformed can the disease be tackled efficiently. For a nation with no infrastructure to support patients with AD and where MRI is unaffordable to the majority and scarcely available PET scans are not used for the diagnosis of AD, the population would rely on the establishment of fluid biomarkers not only for diagnosing AD, but for its identification at a stage where it is possible to reduce the years lost to dependence. Unfortunately, our search on PubMed and Google Scholar revealed only one AD biomarker study conducted by the current authors on our population (4). Recently a constructive step was taken by lay and professional experts where a SWOT analysis was done of dementia research capacity in Pakistan. ---Continue
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通往危机之路:巴基斯坦痴呆症研究成果现状
南亚地区估计有650万痴呆症患者,这些地区处于应对这一日益严重的流行病的前沿。然而,以人口为基础的研究缺乏,特别是在中低收入国家,这阻碍了对痴呆症造成的经济负担的准确估计(1)。巴基斯坦是世界上人口增长第三大的国家,是这些国家的典范。尽管《公共卫生应对痴呆症全球行动计划》强调了七个行动领域,但全球痴呆症观察站的报告指出,巴基斯坦在几乎所有领域都表现不佳。相比之下,她的邻国印度、中国和伊朗要好得多。由于没有痴呆症的卫生信息系统,也没有对痴呆症患者的支持或护理,巴基斯坦未能将痴呆症视为公共卫生优先事项(1)。报告显示,巴基斯坦正在起草一项关于痴呆症的国家政策,但没有对国家患病率和成本进行调查(2)。除了人口老龄化,识字率低,心脏病和糖尿病患病率高,使得人口在未来很容易患上AD。此外,低收入和中等收入国家面临的一个特别挑战是,不仅在一般人群中,而且在医疗保健提供者中,与痴呆症相关的耻辱和缺乏认识。阿尔茨海默病国际报告称,全世界近三分之二的医疗从业人员认为痴呆症是正常衰老的一部分(3)。只有改变这些观念,才能有效地解决这种疾病。对于一个没有基础设施来支持阿尔茨海默病患者的国家来说,MRI对大多数人来说是负担不起的,而且很少有PET扫描不用于阿尔茨海默病的诊断,人们将依赖于建立液体生物标志物,不仅用于诊断阿尔茨海默病,而且用于在有可能减少因依赖而损失的年份的阶段进行识别。不幸的是,我们在PubMed和Google Scholar上的搜索只显示了当前作者对我们人群进行的一项AD生物标志物研究(4)。最近,外行和专业专家采取了建设性的步骤,对巴基斯坦的痴呆症研究能力进行了SWOT分析。——继续
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Impact of haemodialysis on plasma carnitine concentrations in haemodialysis patients Surgical-orthodontic with atypical extraction pattern as a treatment for an anterior open bite: a case report Association between hip flexor tightness and lumbar instability in adults Utilization of the complete blood count in diagnosing endemic diseases in Pakistan Is a Therapeutic approach required to treat Insomnia in Pakistan?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1